essence study semaglutide Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults worldwide, yet many cases remain undiagnosed until advanced fibrosis or cirrhosis develops. So, which patients should clinicians actually be screening? The ACCP Endocrine and Metabolism

Early wins can include: Feeling fuller sooner when eating Snacking less often, especially at night Clothes fitting more comfortably More steady energy throughout the day Remember, sustainable results come with consistency

Ozempic (semaglutide) is a GLP-1 receptor agonist approved for adults with type 2 diabetes to help manage blood sugar, to lower the risk of heart attack and stroke in those with heart disease, and to reduce the risk of kidney failure and worsening kidney disease in those with chronic kidney disease

Dietary habits and meal composition also influence symptom durationhigh-fat, large-volume meals tend to exacerbate and prolong gastrointestinal side effects

Store at 2 to 8 degrees Celsius (standard refrigerator temperature) and discard after 28 days

#Ozivy and this group of #GLP1 drugs are PRESCRIPTION ONLY